Top 10 Books about Stock Investing to read in 2018. Read more.

CYTX - Cytori Therapeutics Inc

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

CYTX - Cytori Therapeutics Inc

Industry: Biotechnology Sector: Healthcare Exchange: NASDAQ

Fri 23'rd Feb 2018

PERIOD 2017-11-24 - 2018-02-23
CHANGE -1.44%
PRICE $0.35





Request Prediction

Cytori Therapeutics Inc Stock Analysis

Technical stock analysis for Fri 23'rd Feb 2018

Shorts 0.80% ( 2018-01-31 )
Cash 32.6 mill
Loans 61.7 mill
Beta 3.04
ROA -71.83
Sell candidate since 2018-02-23

Cytori Therapeutics Inc fell by -1.44% in the last day from $0.36 to $0.35 The price has fallen in 5 of the last 10 days , but is still up by 6.84% over the past 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -1 024 712 shares and in total 477 238 shares bought and sold for approximately $169 324.

Access today's Top 5 Sell Candidates


Cytori Therapeutics Inc lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 22.27% during the next 3 months and, with 90% probability hold a price between $0.37 and $0.65 at the end of this period.

Click here for today's Top 5 Trending Companies


Some negative signals were issued as well, and these may have some influence on the near short-term development. Cytori Therapeutics Inc holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $0.37. On a fall, the stock will find some support from the short-term average at $0.34. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal. A sales signal was issued from a pivot top point on Thursday February 22, 2018, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Access today's Top 5 Golden Star Companies

A sell signal from a double top formation was found on Thursday February 22, 2018 and based on theory for this formation the price should fall by -0.04% to $0.32 within 5 trading days since signal was issued (Thursday March 01, 2018).

Relative Strength Index (RSI)

RSI14 is 44 and the stock is currently not being overbought or oversold

Access full RSI 14 and RSI 21 lists

Support & Resistance

Cytori Therapeutics Inc finds support from accumulated volume at $0.34. On the upside the stock meets some resistance from accumulated volume at $0.38, $0.40 and $0.42.

Support: $0.34 Price: $0.35 Resistance: $0.38


This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.02 between high and low, or 6.96%. For the last week the stock has had a daily average volatility of 8.31%.

Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.

Overall risk:

Very Low Low Medium High Very High


Cytori Therapeutics Inc holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Hold/Accumulate to a Sell Candidate.

Trade CYTX CFDs with Plus500

Your capital is at risk.

Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).

Access these features

Auto portfolios gaining up to 30%
Top 5 Candidates in all Lists
Ultimate List Builder
Ad-free browsing

Become a PRO Now

Last donation

Do you find our website useful too?
Help us improve by making a small donation or
Get PRO features